RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
65 hedge funds and large institutions have $281M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
65
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$8.88M | |
| 2 | +$7.42M | |
| 3 | +$5.18M | |
| 4 |
Millennium Management
New York
|
+$2.84M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.48M |
Top Sellers
| 1 | -$7.79M | |
| 2 | -$4.31M | |
| 3 | -$4.03M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.54M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$2.36M |